FFCP PHASE1:Mm9::chr11:98182595..98182598,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=76|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:98182595..98182598,-|id=chr11:98182595..98182598,-|ontology_enrichment_celltype=CL:0002609!2.83e-24!6;CL:0002608!1.42e-08!3|ontology_enrichment_celltype_v019_2=CL:0002609,6.66e-30,6;CL:0000117,8.45e-09,23;CL:0000337,8.45e-09,23|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001954!3.43e-13!7;UBERON:0003022!3.43e-13!7;UBERON:0002421!3.43e-13!7;UBERON:0000349!3.43e-13!7;UBERON:0002600!3.43e-13!7;UBERON:0000956!7.63e-13!21;UBERON:0001869!7.63e-13!21;UBERON:0000203!7.63e-13!21;UBERON:0002791!4.07e-09!29;UBERON:0003528!4.07e-09!29;UBERON:0001893!4.07e-09!29;UBERON:0002020!1.13e-07!34;UBERON:0001851!6.93e-07!1;UBERON:0005889!6.93e-07!1;UBERON:0000470!6.93e-07!1|ontology_enrichment_uberon_v019_2=UBERON:0000956,1.61e-09,21;UBERON:0001869,1.61e-09,21;UBERON:0000203,1.61e-09,21;UBERON:0003528,3.14e-07,29;UBERON:0002791,3.14e-07,29;UBERON:0001893,3.14e-07,29|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.24427534770173,1.75507719831198,0.841299845405528,0,0,0.61245399607477,0.383381884072945,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255715457330331,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.630869845692382,0.205809224758569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170733605754134,0,0,0.183843508450014,0.222246727801615,0,0,0.252697211763798,0,0,0,0.192075457214608,0.114870937911227,0,0,0,0,0,0,0,0,0,0,0,0,0.263069711437843,0,0,0.237270036248348,0,0,0,0,0,0,0,0,0,0|short_description=p@chr11:98182595..98182598,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=76 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:98182595..98182598,- | |||
|description=CAGE_peak_at_chr11:98182595..98182598,- | |||
|id=chr11:98182595..98182598,- | |||
|ontology_enrichment_celltype=CL:0002609!2.83e-24!6;CL:0002608!1.42e-08!3 | |||
|ontology_enrichment_celltype_v019_2=CL:0002609,6.66e-30,6;CL:0000117,8.45e-09,23;CL:0000337,8.45e-09,23 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001954!3.43e-13!7;UBERON:0003022!3.43e-13!7;UBERON:0002421!3.43e-13!7;UBERON:0000349!3.43e-13!7;UBERON:0002600!3.43e-13!7;UBERON:0000956!7.63e-13!21;UBERON:0001869!7.63e-13!21;UBERON:0000203!7.63e-13!21;UBERON:0002791!4.07e-09!29;UBERON:0003528!4.07e-09!29;UBERON:0001893!4.07e-09!29;UBERON:0002020!1.13e-07!34;UBERON:0001851!6.93e-07!1;UBERON:0005889!6.93e-07!1;UBERON:0000470!6.93e-07!1 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000956,1.61e-09,21;UBERON:0001869,1.61e-09,21;UBERON:0000203,1.61e-09,21;UBERON:0003528,3.14e-07,29;UBERON:0002791,3.14e-07,29;UBERON:0001893,3.14e-07,29 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.24427534770173,1.75507719831198,0.841299845405528,0,0,0.61245399607477,0.383381884072945,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255715457330331,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.630869845692382,0.205809224758569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170733605754134,0,0,0.183843508450014,0.222246727801615,0,0,0.252697211763798,0,0,0,0.192075457214608,0.114870937911227,0,0,0,0,0,0,0,0,0,0,0,0,0.263069711437843,0,0,0.237270036248348,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:98182595..98182598,- | |||
}} |
Latest revision as of 12:08, 4 August 2015
Short description: | p@chr11:98182595..98182598, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:98182595..98182598, - |
Coexpression cluster: | MCL_coexpression_mm9:76 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
neuron of cerebral cortex | 6.66e-30 | 6 |
CNS neuron (sensu Vertebrata) | 8.45e-09 | 23 |
neuroblast (sensu Vertebrata) | 8.45e-09 | 23 |
Ontology term | p-value | n |
---|---|---|
cerebral cortex | 1.61e-09 | 21 |
cerebral hemisphere | 1.61e-09 | 21 |
pallium | 1.61e-09 | 21 |
brain grey matter | 3.14e-07 | 29 |
regional part of telencephalon | 3.14e-07 | 29 |
telencephalon | 3.14e-07 | 29 |